SUMMIT THERAPEUTICS, INC.
Updates & Highlights
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 20...
Business Wire ยท about 9 hours ago
Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates
Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates - Read more on Yahoo Finance
Yahoo Finance ยท 2 days ago
Summit Therapeutics Inc. Announces Multiple Ivonescimab Data Sets from Phase III Studies in Advanced Nsclc Patient Populations to Be Featured At ELCC 2026
Summit Therapeutics Inc. Announces Multiple Ivonescimab Data Sets from Phase III Studies in Advanced Nsclc Patient Po...
marketscreener.com ยท about 8 hours ago
Recent Openings
View all 1 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Team information coming soon